PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rewriting a receptor's role

Synaptic molecule works differently than thought; may mean new therapeutic targets for treating Alzheimer's disease

2013-02-20
(Press-News.org) In a pair of new papers, researchers at the University of California, San Diego School of Medicine and the Royal Netherlands Academy of Arts and Sciences upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons, and describe how a compound linked to Alzheimer's disease impacts that receptor and weakens synaptic connections between brain cells.

The findings are published in the Feb. 18 early edition of the Proceedings of the National Academy of Sciences.

Long the object of study, the NMDA receptor is located at neuronal synapses – the multitudinous junctions where brain cells trade electrical and chemical messages. In particular, NMDA receptors are ion channels activated by glutamate, a major "excitatory" neurotransmitter associated with cognition, learning and memory.

"NMDA receptors are well known to allow the passage of calcium ions into cells and thereby trigger biochemical signaling," said principal investigator Roberto Malinow, MD, PhD professor of neurosciences at UC San Diego School of Medicine.

The new research, however, indicates that NMDA receptors can also operate independent of calcium ions. "It turns upside down a view held for decades regarding how NMDA receptors function," said Malinow, who holds the Shiley-Marcos Endowed Chair in Alzheimer's Disease Research in Honor of Dr. Leon Thal (a renowned UC San Diego Alzheimer's disease researcher who died in a single-engine airplane crash in 2007).

Specifically, Malinow and colleagues found that glutamate binding to the NMDA receptor caused conformational changes in the receptor that ultimately resulted in a weakened synapse and impaired brain function.

They also found that beta amyloid – a peptide that comprises the neuron-killing plaques associated with Alzheimer's disease – causes the NMDA receptor to undergo conformational changes that also lead to the weakening of synapses.

"These new findings overturn commonly held views regarding synapses and potentially identify new targets in the treatment of Alzheimer's disease," said Malinow.

###

Co-authors on both papers are Helmut W. Kessels, Center for Neural Circuits and Behavior, Departments of Neuroscience and Biology, UCSD and Netherlands Institute for Neuroscience, Royal Academy of Arts and Sciences; and Sadegh Nabavi, Center for Neural Circuits and Behavior, Departments of Neuroscience and Biology, UC San Diego.

The research was funded in part by the National Institutes of Health (grants MH049159 and AG032132), the Shiley-Marcos Foundation, the Cure Alzheimer's Foundation, and the Internationale Stichting Alzheimer Onderzoek.

END



ELSE PRESS RELEASES FROM THIS DATE:

IU research: Rock-paper-scissors a parable for cycles in finance, fashion, politics and more

IU research: Rock-paper-scissors a parable for cycles in finance, fashion, politics and more
2013-02-20
BLOOMINGTON, Ind. -- Using a grown-up version of the rock-paper-scissors game, Indiana University cognitive scientists offer a new theory of the group dynamics that arise in situations as varied as cycles of fashion, fluctuations of financial markets, eBay bidding wars and political campaign strategies. In a study written about this week in PLOS ONE, the researchers analyzed situations in which each person's decision depends on what they think other people will decide, looking at the riddle of "what you think I think you think I think." What they found, said Seth Frey, ...

New compound holds high promise in battling kidney cancer

New compound holds high promise in battling kidney cancer
2013-02-20
RIVERSIDE, Calif. — Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer. Named TIR-199, the compound targets the "proteasome," a cellular complex in kidney cancer cells, similar to the way the drug bortezomib, approved by the Food and Drug Administration, targets and inhibits the proteasome in multiple myeloma cells, a cancer coming from bone marrow. Michael Pirrung, a distinguished professor of chemistry at UC Riverside, announced the development of TIR-199 in a lecture ...

Diagnosis and treatment now possible for osteoarthritic cats

Diagnosis and treatment now possible for osteoarthritic cats
2013-02-20
VIDEO: Scientists at the University of Montreal's Quebec Research Group in Animal Pharmacology have found a way to recognize and treat osteoarthritis in cats -- a condition that the owner might... Click here for more information. Scientists at the University of Montreal's Quebec Research Group in Animal Pharmacology have found a way to recognize and treat osteoarthritis in cats – a condition that the owner might not notice and that can make even petting painful. "Osteoarthritis ...

Stanford researchers develop tool for reading the minds of mice

2013-02-20
If you want to read a mouse's mind, it takes some fluorescent protein and a tiny microscope implanted in the rodent's head. Stanford scientists have demonstrated a technique for observing hundreds of neurons firing in the brain of a live mouse, in real time, and have linked that activity to long-term information storage. The unprecedented work could provide a useful tool for studying new therapies for neurodegenerative diseases such as Alzheimer's. The researchers first used a gene therapy approach to cause the mouse's neurons to express a green fluorescent protein ...

That's the way the droplets adhere

2013-02-20
CAMBRIDGE, MA -- Understanding exactly how droplets and bubbles stick to surfaces — everything from dew on blades of grass to the water droplets that form on condensing coils after steam drives a turbine in a power plant — is a "100-year-old problem" that has eluded experimental answers, says MIT's Kripa Varanasi. Furthermore, it's a question with implications for everything from how to improve power-plant efficiency to how to reduce fogging on windshields. Now this longstanding problem has finally been licked, Varanasi says, in research he conducted with graduate student ...

Artful science

Artful science
2013-02-20
There are "things hidden in plain sight" all around us. But art can help students see their world anew, unlocking discoveries in fields ranging from plant biology to biomedical imaging, according to University of Delaware professor John Jungck. Jungck's sentiments were echoed by a panel of experts speaking on "Artful Science" on Feb. 15 at the annual meeting of the American Association for the Advancement of Science (AAAS) in Boston. Jungck organized the panel and also spoke at the event. Canoeing on a lake near his home in northwestern Minnesota when he was a youngster, ...

Powerful people are looking out for their future selves

2013-02-20
Would you prefer $120 today or $154 in one year? Your answer may depend on how powerful you feel, according to new research in Psychological Science, a journal of the Association for Psychological Science. Many people tend to forego the larger reward and opt for the $120 now, a phenomenon known as temporal discounting. But research conducted by Priyanka Joshi and Nathanael Fast of the University of Southern California Marshall School of Business suggests that people who feel powerful are more likely to wait for the bigger reward, in part because they feel a stronger connection ...

Engineering control theory helps create dynamic brain models

2013-02-20
BOSTON -- Models of the human brain, patterned on engineering control theory, may some day help researchers control such neurological diseases as epilepsy, Parkinson's and migraines, according to a Penn State researcher who is using mathematical models of neuron networks from which more complex brain models emerge. "The dual concepts of observability and controlability have been considered one of the most important developments in mathematics of the 20th century," said Steven J. Schiff, the Brush Chair Professor of Engineering and director of the Penn State Center for ...

New approach alters malaria maps

2013-02-20
UNIVERSITY PARK, Pa. – Identifying areas of malarial infection risk depends more on daily temperature variation than on the average monthly temperatures, according to a team of researchers, who believe that their results may also apply to environmentally temperature-dependent organisms other than the malaria parasite. "Temperature is a key driver of several of the essential mosquito and parasite life history traits that combine to determine transmission intensity, including mosquito development rate, biting rate, development rate and survival of the parasite within the ...

Mutant champions save imperiled species from almost-certain extinction

Mutant champions save imperiled species from almost-certain extinction
2013-02-20
Species facing widespread and rapid environmental changes can sometimes evolve quickly enough to dodge the extinction bullet. Populations of disease-causing bacteria evolve, for example, as doctors flood their "environment," the human body, with antibiotics. Insects, animals and plants can make evolutionary adaptations in response to pesticides, heavy metals and overfishing. Previous studies have shown that the more gradual the change, the better the chances for "evolutionary rescue" – the process of mutations occurring fast enough to allow a population to avoid extinction ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Rewriting a receptor's role
Synaptic molecule works differently than thought; may mean new therapeutic targets for treating Alzheimer's disease